Paris - Delayed Quote EUR

Virbac SA (VIRP.PA)

Compare
302.00
-0.50
(-0.17%)
At close: January 24 at 5:35:10 PM GMT+1
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,246,901.00
1,246,901.00
1,216,187.00
1,063,966.00
934,199.00
Cost of Revenue
437,303.00
437,303.00
426,221.00
363,093.00
319,941.00
Gross Profit
809,598.00
809,598.00
789,966.00
700,873.00
614,258.00
Operating Expense
623,895.00
623,895.00
607,676.00
534,107.00
491,381.00
Operating Income
185,703.00
185,703.00
182,290.00
166,766.00
122,877.00
Net Non Operating Interest Income Expense
256.00
256.00
1,000.00
-3,793.00
-8,761.00
Pretax Income
174,153.00
174,153.00
176,443.00
159,107.00
173,323.00
Tax Provision
53,520.00
53,520.00
55,649.00
43,612.00
33,286.00
Net Income Common Stockholders
121,298.00
121,298.00
121,967.00
113,162.00
136,039.00
Diluted NI Available to Com Stockholders
121,298.00
121,298.00
121,967.00
113,162.00
136,039.00
Basic EPS
14.40
--
14.43
13.40
16.12
Diluted EPS
14.38
--
14.42
13.38
16.12
Basic Average Shares
8,421.79
--
8,448.18
8,442.11
8,436.70
Diluted Average Shares
8,437.21
--
8,454.27
8,458.00
8,436.70
Total Operating Income as Reported
184,876.00
184,876.00
179,519.00
167,626.00
183,748.00
Total Expenses
1,061,198.00
1,061,198.00
1,033,897.00
897,200.00
811,322.00
Net Income from Continuing & Discontinued Operation
121,298.00
121,298.00
121,967.00
113,162.00
136,039.00
Normalized Income
118,397.51
118,397.51
127,505.00
119,413.76
91,083.13
Interest Income
8,724.00
8,724.00
4,831.00
2,369.00
2,019.00
Interest Expense
8,882.00
8,882.00
3,691.00
5,982.00
10,716.00
Net Interest Income
256.00
256.00
1,000.00
-3,793.00
-8,761.00
EBIT
183,035.00
183,035.00
180,134.00
165,089.00
184,039.00
EBITDA
230,653.00
230,653.00
229,200.00
208,433.00
241,732.00
Reconciled Cost of Revenue
437,303.00
437,303.00
426,221.00
363,093.00
319,941.00
Reconciled Depreciation
47,618.00
47,618.00
49,066.00
38,909.00
57,693.00
Net Income from Continuing Operation Net Minority Interest
121,298.00
121,298.00
121,967.00
113,162.00
136,039.00
Total Unusual Items Excluding Goodwill
3,982.00
3,982.00
-7,800.00
-8,529.00
62,283.00
Total Unusual Items
3,982.00
3,982.00
-7,800.00
-8,529.00
62,283.00
Normalized EBITDA
226,671.00
226,671.00
237,000.00
216,962.00
179,449.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
1,081.51
1,081.51
-2,262.00
-2,277.24
17,327.13
12/31/2020 - 7/7/1992

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SNW2.MU Sanofi SA
49.80
+0.81%
 
GS71.DE GSK plc
16.26
-0.25%
 
JNJ.HM Johnson & Johnson
140.08
-1.16%
 
SAN.PA Sanofi
100.16
+0.27%
 
AZN.L AstraZeneca PLC
11,050.00
+0.04%
 
ROG.SW Roche Holding AG
274.90
+0.18%
 
NOVO-B.CO Novo Nordisk A/S
622.40
+7.13%
 
MRK Merck & Co., Inc.
95.55
-1.12%
 
NVO Novo Nordisk A/S
87.97
+8.47%
 
PFE Pfizer Inc.
26.09
+0.31%